Careland Plantar Fasciitis Hydrogel Pain Patches Patch
NDC Package 75568-017-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Careland Plantar Fasciitis Hydrogel Pain Patches (lidocaine, menthol) patches is adults and children 12 years of age and over:clean and dry affected arearemove film from patch and apply to the skinapply 1 patch at a time to affected area, not more than 3 to 4 times dailyChidren under 12 years of age:consult a doctor. This formulation utilizes a patch delivery system. Marketed by Planet (anhui) Pharmaceutical Co., Ltd., this product is identified by NDC 75568-017 and is authorized under FDA application M017.

Identification & Billing

NDC Package Code
75568-017-01
Package Description
8 POUCH in 1 BOX / 3 g in 1 POUCH
Product Code
75568-017
11-Digit Billing Format
75568001701
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Careland Plantar Fasciitis Hydrogel Pain Patches
Non-Proprietary Name
Lidocaine, Menthol
Substance Name
Lidocaine; Menthol
Dosage Form
Patch - A drug delivery system that often contains an adhesive backing that is usually applied to an external site on the body. Its ingredients either passively diffuse from, or are actively transported from, some portion of the patch. Depending upon the patch, the ingredients are either delivered to the outer surface of the body or into the body. A patch is sometimes synonymous with the terms ‘extended release film’ and ‘system’.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Adults and children 12 years of age and over:clean and dry affected arearemove film from patch and apply to the skinapply 1 patch at a time to affected area, not more than 3 to 4 times dailyChidren under 12 years of age:consult a doctor

Regulatory & Marketing

Labeler Name
Planet (anhui) Pharmaceutical Co., Ltd.
Product Type
Human Otc Drug
FDA Application #
M017
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
08-10-2024
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 75568-017-01 identifies a specific commercial package of 8 pouch in 1 box / 3 g in 1 pouch of Careland Plantar Fasciitis Hydrogel Pain Patches, a human over the counter drug labeled by Planet (anhui) Pharmaceutical Co., Ltd.. This patch is formulated for topical use and contains lidocaine; menthol as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Planet (anhui) Pharmaceutical Co., Ltd. on August 10, 2024. The current certification is valid through December 31, 2026.

How is this Planet (anhui) Pharmaceutical Co., Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 75568001701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
75568-017-01
11-Digit CMS (5-4-2)
75568-0017-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.